Faculté de Médecine
Impact Points
Publications
Top Journals
Top Newcomers
Publications (75)
-
Article: [Is cholecystokinin a biological support in panic attacks?].
L Encéphale 17(5):475-9. · 0.63 Impact Factor -
Article: Clinical Testing of Anxiolytic Drugs
-
Article: [Software modeling for better understanding of pharmacokinetic-pharmacodynamic relationships: application to azithromycin in the treatment of streptococcal tonsillitis and in acute exacerbation fo chronic bronchitis]].
Thérapie 59(1):155-62. · 0.30 Impact Factor -
Article: A new experimental rat model of osteosarcoma established by intrafemoral tumor cell inoculation, useful for biology and therapy investigations.
Tumor Biology 26(3):121-30. · 1.94 Impact Factor -
Article: [Neurotoxicity of ketamine and midazolam by intrathecal injection in the rabbit].
Annales Françaises d Anesthésie et de Réanimation 02/1989; 8 Suppl:R174. · 0.84 Impact Factor -
Article: [Clinical and neurobiological aspects of long-term administration of psychotropic drugs].
Canadian journal of psychiatry. Revue canadienne de psychiatrie 06/1991; 36(4):260-4. · 2.42 Impact Factor -
Article: Possible involvement of TGF beta 1 in the distinct tumorigenic properties of two rat colon carcinoma clones
Invasion and Metastasis 02/1992; 12(3-4):185-96. -
Article: [From inducers of panic attack to neurobiology of panic disorder].
L Encéphale 01/1997; 22 Spec No 5:35-41. · 0.63 Impact Factor -
Article: Cholecystokinin as a target for neuropsychiatric drugs.
Drug News & Perspectives 09/1998; 11(6):342-9. · 2.21 Impact Factor -
Article: gp130 Cytokine family and bone cells.
Cytokine 11/2000; 12(10):1455-68. · 3.02 Impact Factor -
Article: Drug mechanisms in anxiety.
Current opinion in investigational drugs (London, England: 2000) 03/2001; 2(2):259-65. · 3.31 Impact Factor -
Article: Cyamemazine as an anxiolytic drug on the elevated plus maze and light/dark paradigm in mice.
Behavioural Brain Research 10/2001; 124(1):87-95. · 3.42 Impact Factor -
Article: Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disorders.
Cytokine & Growth Factor Reviews 07/2002; 13(3):241-57. · 7.81 Impact Factor -
Article: Combination of quinupristin-dalfopristin and gentamicin against methicillin-resistant Staphylococcus aureus: experimental rabbit endocarditis study.
Antimicrobial Agents and Chemotherapy 07/2002; 46(7):2174-8. · 4.84 Impact Factor -
Article: Identification of SLC39A4, a gene involved in acrodermatitis enteropathica.
Nature Genetics 08/2002; 31(3):239-40. · 35.53 Impact Factor -
Article: Nicotinic receptors and Alzheimer's disease.
Current Medical Research and Opinion 02/2003; 19(3):169-77. · 2.38 Impact Factor -
Article: The mouse light/dark box test.
European Journal of Pharmacology 03/2003; 463(1-3):55-65. · 2.52 Impact Factor -
Article: Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review.
Human Psychopharmacology Clinical and Experimental 05/2003; 18(3):185-90. · 2.48 Impact Factor -
Article: Mutation spectrum of human SLC39A4 in a panel of patients with acrodermatitis enteropathica.
Human Mutation 10/2003; 22(4):337-8. · 5.69 Impact Factor -
Article: [Antibiotic therapy: from pharmacology to decision making].
La Revue du praticien 10/2003; 53(14):1554-60. -
Article: Preclinical and clinical pharmacology of cyamemazine: anxiolytic effects and prevention of alcohol and benzodiazepine withdrawal syndrome.
CNS Drug Reviews 02/2004; 10(3):219-29. · 4.92 Impact Factor -
Article: Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors.
Journal of psychiatry & neuroscience: JPN 04/2004; 29(2):126-33. · 5.34 Impact Factor -
Article: Nicotinic receptors and schizophrenia.
Current Medical Research and Opinion 08/2004; 20(7):1057-74. · 2.38 Impact Factor -
Article: Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma.
BMC Cancer 02/2005; 5:123. · 3.01 Impact Factor -
Article: Molecular cloning and characterization of FBXO47, a novel gene containing an F-box domain, located in the 17q12 band deleted in papillary renal cell carcinoma.
Genes Chromosomes and Cancer 06/2005; 43(1):83-94. · 3.31 Impact Factor -
Article: Anxiolytic-like effect of milnacipran in the four-plate test in mice: mechanism of action.
Pharmacology Biochemistry and Behavior 08/2005; 81(3):645-56. · 2.53 Impact Factor -
Article: Evidence for the activity of lamotrigine at 5-HT(1A) receptors in the mouse forced swimming test.
Journal of psychiatry & neuroscience: JPN 08/2005; 30(4):275-82. · 5.34 Impact Factor -
Article: A proposal of decision tree to screen putative antidepressants using forced swim and tail suspension tests.
Behavioural Brain Research 12/2005; 164(2):266-9. · 3.42 Impact Factor -
Article: Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing mice.
Cancer 01/2006; 104(11):2522-9. · 4.77 Impact Factor -
Article: RANKL directly induces bone morphogenetic protein-2 expression in RANK-expressing POS-1 osteosarcoma cells.
International Journal of Oncology 02/2006; 28(1):261-9. · 2.40 Impact Factor -
Article: [Pharmacology of antipsychotic drugs]].
L Encéphale 02/2006; 32 Pt 2:S8-9. · 0.63 Impact Factor -
Article: Osteosarcoma: current status of immunotherapy and future trends (Review).
Oncology Reports 04/2006; 15(3):693-700. · 1.84 Impact Factor -
Article: The role of mood stabilisers in the treatment of the depressive facet of bipolar disorders.
Neuroscience & Biobehavioral Reviews 02/2007; 31(6):963-75. · 8.65 Impact Factor -
Article: Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies.
Expert Review of Anti-infective Therapy 03/2007; 7(2):169-81. · 2.65 Impact Factor -
Article: TOM22, a core component of the mitochondria outer membrane protein translocation pore, is a mitochondrial receptor for the proapoptotic protein Bax.
Cell Death and Differentiation 05/2007; 14(4):785-94. · 8.85 Impact Factor -
Article: [Sleep and wakefulness drugs and their indications].
Annales Pharmaceutiques Françaises 08/2007; 65(4):251-7. -
Article: Evidence of lowest brain penetration of an antiemetic drug, metopimazine, compared to domperidone, metoclopramide and chlorpromazine, using an in vitro model of the blood-brain barrier.
Pharmacological Research 08/2007; 56(1):11-7. · 4.44 Impact Factor -
Article: Immune responses to gene product of inducible promoters.
Current Gene Therapy 11/2007; 7(5):334-46. · 3.39 Impact Factor -
Article: Mucosal IL-10 and TGF-beta play crucial roles in preventing LPS-driven, IFN-gamma-mediated epithelial damage in human colon explants.
Journal of Clinical Investigation 04/2008; 118(3):1132-42. · 15.39 Impact Factor -
Article: Perineal pain and inferior cluneal nerves: anatomy and surgery.
Surgical and Radiologic Anatomy 06/2008; 30(3):177-83. · 1.06 Impact Factor -
Article: Safety and efficacy of regional intravenous (r.i.) versus intramuscular (i.m.) delivery of rAAV1 and rAAV8 to nonhuman primate skeletal muscle.
Molecular Therapy 08/2008; 16(7):1291-9. · 6.87 Impact Factor -
Article: RANKL/RANK/OPG: key therapeutic target in bone oncology.
Current Drug Discovery Technologies 09/2008; 5(3):263-8. -
Article: Serotonin1B heteroreceptor activation induces an antidepressant-like effect in mice with an alteration of the serotonergic system.
Journal of psychiatry & neuroscience: JPN 12/2008; 33(6):541-50. · 5.34 Impact Factor -
Article: Intermittent active motion versus immobilization in the treatment of Staphylococcus aureus-induced arthritis in a rabbit model.
Journal of Children s Orthopaedics 01/2009; 2(6):491-5. -
Article: The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis.
Diabetes & Metabolism 01/2009; 34(6 Pt 2):685-91. · 2.41 Impact Factor -
Article: Melatonin receptor agonist agomelatine: a new drug for treating unipolar depression.
Current pharmaceutical design 02/2009; 15(14):1675-82. · 4.41 Impact Factor -
Article: In situ evidence of involvement of Schwann cells in ulcerative colitis: autocrine and paracrine signaling by A disintegrin and metalloprotease-17-mediated tumor necrosis factor alpha production.
Human pathology 05/2009; 40(8):1159-67. · 3.03 Impact Factor -
Article: FITC-albumin as a marker for assessment of endothelial permeability in mice: comparison with 125I-albumin.
Experimental Lung Research 05/2009; 35(4):263-71. · 1.22 Impact Factor -
Article: [Cell therapy for acute myocardial infarction].
Transfusion Clinique et Biologique 06/2009; 16(2):146-7. · 0.80 Impact Factor -
Article: Augmentation effect of combination therapy of aripiprazole and antidepressants on forced swimming test in mice.
Psychopharmacologia 07/2009; 206(1):97-107. · 4.08 Impact Factor
284.56
Total Impact Points
75
Publications
3.79
Avg. Impact Points
236
Authors
5.09
Avg. Authors Per Publ.